Skip to main content

FDA To Conduct Talc-Asbestos Test Methods Meeting

FDA To Conduct Talc-Asbestos Test Methods Meeting

FDA To Conduct Talc-Asbestos Test Methods Meeting

Introduction

FDA will hold a meeting next month to discuss testing methods for the baby powder, following a nationwide recall after federal regulators found segments of asbestos particles in Johnson & Johnson's (J&J) talcum powder .

The public meeting is scheduled for February 4, where the FDA will hear testimony about the best possible methods to test asbestos in talc, and talc-containing cosmetic products, from the experts. The meeting will also include discussion and presentation of scientific data, information on the testing methodologies, and terminology and criteria. According to the agency, even after using the most sensitive electron microscopy methods, laboratories may get different results, which leads to a lack of uniformity for testing.

The recall that happened last year was the result of a survey conducted by the FDA for 50 talc-containing cosmetic products. The recall impacted around 33,000 bottles sold in stores nationwide.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!